- Pfizer Inc.
- Warner-Lambert Co.
- Glaxo Wellcome PLC
- Eisai Co. Ltd.
- Bristol-Myers Squibb Co.
- SmithKline Beecham
- AstraZeneca PLC
- Nektar Therapeutics
- Eli Lilly & Co.
- Merck & Co. Inc.
- Forest Laboratories Inc.
- inVentiv Health Inc.
- Innovex Inc.
- Quintiles Transnational Holdings Inc.
- CV Therapeutics Inc.
- American Home Products to buy Warner-Lambert; withdrawn
- Pfizer co-promotes Searle's Cox-2 inhibitor
- Glaxo acquires Wellcome in $14 billion hostile bid
- Roche buys Boehringer Mannheim and DePuy from Corange
- Pfizer to help develop and market Eisai's Alzheimer's drug
- BMS and SB to co-promote Avandia for Type II diabetes
- Parke-Davis' Celexa US co-promotion deal with Forest ends
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.